StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > This is the most important blurp

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Nov 23, 2020 9:55am

121 Views

Post# 31951589

RE:This is the most important blurp

Makes sense. According to the intake list they are testing for over 50 businesses,including a large county in Arizona. Who knows what else that we can't find. Add in Barbados and Hawaii and I can see why the need for hiring additional staff and expanding the lab. Can't wait for a corporate update once the Offering officially closes.